Acute and chronic effects of agomelatine on intravenous penthylenetetrazol-induced seizure in mice and the probable role of nitric oxide

European Journal of Pharmacology

Volumn 736, Issue , 2014, Pages 10-15

  Dastgheib, Mona ^a   Moezi, Leila ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agomelatine; Mice; Nitric oxide; Penthylenetetrazol; Seizure

Indexed keywords

7 NITROINDAZOLE; AGOMELATINE; AMINOGUANIDINE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTETRAZOLE; 7-NITROINDAZOLE; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT; CONVULSANT AGENT; GUANIDINE DERIVATIVE; INDAZOLE DERIVATIVE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG EFFECT; LATENT PERIOD; MALE; MOTOR COORDINATION; MOUSE; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PSYCHOMOTOR PERFORMANCE; ROTAROD TEST; SEIZURES;

ACETAMIDES; ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTICONVULSANTS; CONVULSANTS; GUANIDINES; INDAZOLES; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTYLENETETRAZOLE; PSYCHOMOTOR PERFORMANCE; ROTAROD PERFORMANCE TEST; SEIZURES;

EID: 84900368469     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.04.039     Document Type: Article

References (35)

1. D. Acuna-Castroviejo, G. Escames, L.C. Lopez, A.B. Hitos, and J. Leon Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis Endocrine 27 2005 159 168 (Pubitemid 41558448)
2. C.C. Aguiar, A.B. Almeida, P.V. Araujo, G.S. Vasconcelos, E.M. Chaves, O.C. do Vale, D.S. Macedo, F.C. de Sousa, G.S. Viana, and S.M. Vasconcelos Anticonvulsant effects of agomelatine in mice Epilepsy Behav. 24 2012 324 328
3. 2C receptors J. Neurochem. 64 1995 2473 2479
4. T.E. Albertson, S.L. Peterson, L.G. Stark, M.L. Lakin, and W.D. Winters The anticonvulsant properties of melatonin on kindled seizures in rats Neuropharmacology 20 1981 61 66 (Pubitemid 11213164)
5. V. Bertaina-Anglade, C.D. la Rochelle, P.A. Boyer, and E. Mocaer Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model Behav. Pharmacol. 17 2006 703 713
6. I. Bettahi, D. Pozo, C. Osuna, R.J. Reiter, D. Acuna-Castroviejo, and J.M. Guerrero Melatonin reduces nitric oxide synthase activity in rat hypothalamus J. Pineal Res. 20 1996 205 210 (Pubitemid 126733163)
7. L. Bikjdaouene, G. Escames, J. Leon, J.M. Ferrer, H. Khaldy, F. Vives, and D. Acuna-Castroviejo Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures J. Pineal Res. 35 2003 54 60 (Pubitemid 36819171)
8. K.K. Borowicz, R. Kaminski, M. Gasior, Z. Kleinrok, and S.J. Czuczwar Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice Eur. Neuropsychopharmacol. 9 1999 185 190 (Pubitemid 29114922)
9. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
10. M.J. Brodie, and M.A. Dichter Antiepileptic drugs N. Engl. J. Med. 334 1996 168 175
11. A. Cagnacci Melatonin in relation to physiology in adult humans J. Pineal Res. 21 1996 200 213 (Pubitemid 126733136)
12. T.H. Champney, W.H. Hanneman, M.E. Legare, and K. Appel Acute and chronic effects of melatonin as an anticonvulsant in male gerbils J. Pineal Res. 20 1996 79 83 (Pubitemid 126733178)
13. G.B. De Sarro, E. Donato Di Paola, A. De Sarro, and M.J. Vidal Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex Fundam. Clin. Pharmacol. 5 1991 503 511
14. P. Delagrange, and J.A. Boutin Therapeutic potential of melatonin ligands Chronobiol. Int. 23 2006 413 418 (Pubitemid 43739052)
15. C. Durlach-Misteli, and J.M. Van Ree Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs Eur. J. Pharmacol. 217 1992 15 21
16. 2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin FASEB J. 18 2004 1646 1656 (Pubitemid 39463704)
17. B. Guardiola-Lemaitre Toxicology of melatonin J. Biol. Rhythms 12 1997 697 706
18. 2C) receptor antagonist-induced effects in REM sleep, wake and theta wave activity Exp. Brain Res. 232 2014 935 946
19. 2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study Int. Clin. Psychopharmacol. 17 2002 239 247
20. R.H. Mattson Drug treatment of uncontrolled seizures Epilepsy Res. Suppl. 5 1992 29 35
21. M. Mevissen, and U. Ebert Anticonvulsant effects of melatonin in amygdala-kindled rats Neurosci. Lett. 257 1998 13 16 (Pubitemid 28546893)
22. 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways J. Pharmacol. Exp. Ther. 306 2003 954 964 (Pubitemid 37025301)
23. 2 receptor agonist: a novel therapeutic drug for sleep disorders CNS Neurosci. Ther. 15 2009 32 51
24. K. Osonoe, N. Mori, K. Suzuki, and M. Osonoe Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats Brain Res. 663 1994 338 340 (Pubitemid 24339052)
25. M. Papp, P. Gruca, P.A. Boyer, and E. Mocaer Effect of agomelatine in the chronic mild stress model of depression in the rat Neuropsychopharmacology. 28 2003 694 703
26. D. Pozo, R.J. Reiter, J.R. Calvo, and J.M. Guerrero Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin J. Cell. Biochem. 65 1997 430 442 (Pubitemid 27190697)
27. M. Ray, P.K. Mediratta, K. Reeta, P. Mahajan, and K.K. Sharma Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures Methods. Find. Exp. Clin. Pharmacol. 26 2004 177 181 (Pubitemid 38639381)
28. R.J. Reiter Pineal melatonin: cell biology of its synthesis and of its physiological interactions Endocr. Rev. 12 1991 151 180
29. R.A. Sansone, and L.A. Sansone Agomelatine: a novel antidepressant Innov. Clin. Neurosci. 8 2011 10 14
30. S.H. Snyder, and D.S. Bredt Nitric oxide as a neuronal messenger Trends Pharmacol. Sci. 12 1991 125 128
31. M.S. Starr, and B.S. Starr Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME Pharmacol. Biochem. Behav. 45 1993 321 325
32. 2C) receptor system: effector pathway and agonist dependence J. Pharmacol. Exp. Ther. 302 2002 957 962 (Pubitemid 34920216)
33. M. Tsuda, T. Suzuki, and M. Misawa Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice Life Sci. 60 1997 PL339 PL343
34. P.A. Witt-Enderby, J. Bennett, M.J. Jarzynka, S. Firestine, and M.A. Melan Melatonin receptors and their regulation: biochemical and structural mechanisms Life Sci. 72 2003 2183 2198 (Pubitemid 36292142)
35. N. Yahyavi-Firouz-Abadi, P. Tahsili-Fahadan, K. Riazi, M.H. Ghahremani, and A.R. Dehpour Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice Epilepsy Res. 68 2006 103 113 (Pubitemid 43155756)